pH-responsive mesoporous silica nanorod for high load and oral delivery of insulin
Ding Hu,Yuxing Li,Wenqi Teng,Fuqiang Li,Linrui Li,Miao Li,Liu Tan,Zhimin Wu
DOI: https://doi.org/10.1016/j.jddst.2023.105256
IF: 5
2023-12-11
Journal of Drug Delivery Science and Technology
Abstract:Diabetes is a metabolic disease often characterized by elevated blood sugar levels, which is mainly treated through external injection of insulin. However, long-term insulin injection in patients will produce many adverse side effects such as hypoglycemia, subcutaneous fat atrophy and prolonged absorption, resulting in poor patient compliance. In this work, mesoporous silica (SBA-15) nanorods with large surface area (541.8 m 2 /g) were prepared via soft-templating method, which retained a large number of ordered mesoporous structures as the drug delivery carrier for insulin. Insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS). The surface area, structure and morphology of silica particles were addressed by BET, FTIR, XRD, SEM and TEM, indicating that SBA-15/INS and HP55@SBA-15/INS maintained the rod-like and ordered white strips structure similar to SBA-15. Also, insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The vitro release results revealed that insulin release in the simulated gastric fluid (SGF, pH = 1.2) was significantly slower than that in the simulated intestinal fluid (SIF, pH = 7.4). Compared with SBA-15/INS, the release percentages in 15 % HP55@SBA-15/INS decreased 30 % in SGF, while it increased approximately 10 % in SIF. Kinetics analysis showed that the release process in HP55@SBA-15/INS was a Fick diffusion in both SGF and SIF and HP55 was degraded in SIF, resulting in accelerated insulin release. The cytotoxicity evaluation results showed that the cell viability of 4T1 after 24 h incubated with SBA-15 and 15 % HP55@SBA-15/INS was both approximately 100 %, demonstrating that the facile manufactured method has great potential to prepare macromolecular drug nanoparticle for oral release. Graphical abstract Fig.1 Schematic illustration of the fabrication of HP55@SBA-15/INS and its application in oral delivery of insulinThis paper reports a facile synthesis of pH-responsive mesoporous silica nanorod for oral delivery of insulin. As shown in Fig.1, insulin-loaded mesoporous silica (SBA-15/INS) particle was obtained by solvent adsorption, which was then coated with hydroxypropyl methylcellulose phthalate (HP55) to form pH-sensitive mesoporous silica nanoparticles (HP55@SBA-15/INS) via double emulsion solvent evaporation method. The insulin was found to be present in the mesoporous silica nanoparticles, with loading capacity and encapsulation efficiency reaching 25.5 % and 80.9 %, respectively. The HP55@SBA-15/INS nanoparticles show excellent release performance in simulated intestinal fluid (SIF, pH = 7.4) without observable cytotoxicity. And, the release process in HP55@SBA-15/INS is demonstrated to a Fick diffusion in SIF. More importantly, this synthesis method can be widely used to load other protein drug for oral delivery, which will produce various novel nanomedicines of different clinical applications. Download : Download high-res image (139KB) Download : Download full-size image
pharmacology & pharmacy